Sept 30 (Reuters) - Biocartis Group NV BCART.BR :
* REG-PRESS NEWS BIOCARTIS GROUP NV: BIOCARTIS RECEIVES EUR
1.2
MILLION GRANT FOR DEVELOPMENT OF HIGHLY INNOVATIVE IDYLLA™
GENEFUSION ASSAY
* EXPECTS TO LAUNCH ITS IDYLLA GENEFUSION ASSAY AS A
RESEARCH USE
ONLY (RUO) ASSAY IN Q1 2021
* VALIDATION AND RELEASE OF AN IVD VERSION FOR USE IN NSCLC
IS
ALSO ANTICIPATED.
Source text for Eikon: ID:nGNE3mLPFy
Further company coverage: BCART.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))